Leukemia Program At Massachusetts News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Leukemia Program At Massachusetts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Leukemia Program At Massachusetts Today - Breaking & Trending Today

PureTech Receives Orphan Drug Designation for LYT-200 in Acute Myeloid Leukemia

Published: March 13, 2024

LYT-200 is being advanced in hematological malignancies such as acute myeloid leukemia and high-risk myelodysplastic syndrome , and locally advanced/metastatic solid tumors, including head and neck...

Source: marketscreener.com

Related Topics:

United StatesAmir FathiAleksandra FilipovicPuretech HealthLeukemia Program At MassachusettsDrug AdministrationLeukemia ProgramMassachusetts General HospitalOrphan Drug ActFounded Entity GallopFounded EntitiesPrivate Securities Litigation Reform ActAnnual Report

FDA Grants Orphan Drug Designation to LYT-200 in AML

Published: March 13, 2024

The FDA has granted orphan drug designation to LYT-200 for the treatment of acute myeloid leukemia.

Source: onclive.com

Related Topics:

United StatesAmir FathiAleksandra FilipovicLeukemia Program At MassachusettsPuretech HealthOncology CongressInternational Prognostic Scoring SystemLeukemia ProgramMassachusetts General Hospital